Tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), while widely adopted in clinical practice, possess low sensitivity and specificity in diagnosing early GC (4). The gene discussed is CEACAM5; the disease is neoplasm.